Journal of Child and Adolescent Psychopharmacology

Journal of Child and Adolescent Psychopharmacology is published by Mary Ann Liebert Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Attention Deficit Hyperactivity Disorder, Child and Adolescent Psychosocial and Emotional Development and Bipolar Disorder and Treatment, together about 45% of its articles. Its main subfields are Psychiatry and Mental health. (generated from OpenAlex topic counts and CAS ranking data)

Journal of Child and Adolescent Psychopharmacology (JCAP) is the premier peer-reviewed journal covering the clinical aspects of treating this patient population with psychotropic medications including side effects and interactions, standard doses, and research on new and existing medications. The Journal includes information on related areas of medical sciences such as advances in developmental pharmacokinetics, developmental neuroscience, metabolism, nutrition, molecular genetics, and more. Journal of Child and Adolescent Psychopharmacology coverage includes: New drugs and treatment strategies including the use of psycho-stimulants, selective serotonin reuptake inhibitors, mood stabilizers, and atypical antipsychotics New developments in the diagnosis and treatment of ADHD, anxiety disorders, schizophrenia, autism spectrum disorders, bipolar disorder, eating disorders, along with other disorders Reports of common and rare Treatment Emergent Adverse Events (TEAEs) including: hyperprolactinemia, galactorrhea, weight gain/loss, metabolic syndrome, dyslipidemia, switching phenomena, sudden death, and the potential increase of suicide. Outcomes research.

Source: LetPub

Research area (LetPub): Psychiatry

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

1.73LetPub · 2026-09-13

CiteScore 2026-06

3.8LetPub · 2026-09-13

SJR 2026-06

0.62LetPub · 2026-09-13

SNIP 2026-06

0.67LetPub · 2026-09-13

h-index

77LetPub · 2026-09-13

h-index

117OpenAlex · 2026-10-01

i10-index

1,639OpenAlex · 2026-10-01

2-year mean citedness

2.28OpenAlex · 2026-10-01

Self-citation rate

22.2%LetPub · 2026-09-13

Share of gold OA articles

8.82%LetPub · 2026-09-13

Volume

Articles per year

53LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Average review time (community reports)

over 12 weeksLetPub · 2026-09-13

Average acceptance (community reports)

Fairly easyLetPub · 2026-09-13

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Publisher

Mary Ann Liebert Inc.

Country or region

UNITED STATES

Language

English

Frequency

Quarterly

Founded

1990

ISSN

1044-5463

Electronic ISSN

1557-8992

Official links

• Journal homepage ↗LetPub
• Submission system ↗LetPub